United States · FDA National Drug Code directory
Angeliq
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50419-483_261d4ace-5c4e-48f6-b793-354492017e89
- Product NDC
- 50419-483
- Form
- TABLET, FILM COATED
- Composition / generic term
- drospirenone and estradiol
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20051128
- Source listing expiry
- 20271231
Source-listed ingredients
- ESTRADIOL — 1 mg/1
- DROSPIRENONE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (50419-483-03) / 28 TABLET, FILM COATED in 1 BLISTER PACK (50419-483-01) · 50419-483-03
- 1 BLISTER PACK in 1 CARTON (50419-483-72) / 14 TABLET, FILM COATED in 1 BLISTER PACK (50419-483-71) · 50419-483-72
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →